This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sparkowski, J. Articles by Schlegel, R. Search for Related Content PubMed PubMed Citation Articles by Sparkowski, J. Articles by Schlegel, R.

 Previous Article  |  Next Article 

J. Virol., Apr 1996, 2420-2430, Vol 70, No. 4
Copyright © 1996, American Society for Microbiology

E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation

J Sparkowski, M Mense, J Anders and R Schlegel
Department of Pathology, Georgetown University Medical School, Washington, D.C. 20007, USA.

The E5 oncoprotein of bovine papillomavirus type 1 is a 44-amino-acid, hydrophobic polypeptide which localizes predominantly in Golgi membranes and appears to transform cells through the activation of tyrosine kinase growth factor receptors. In fibroblasts, E5 interacts with both the 16-kilodalton vacuolar ATPase subunit and the platelet- derived growth factor receptor (PDGF-R) via its hydrophobic transmembrane domain and induces autophosphorylation of the receptor. To further analyze the correlation between E5 biological activity and its ability to bind these cellular proteins, a series of nine E5 transmembrane mutants was evaluated. In 32D mouse hematopoietic cells, there was an incomplete correlation between the abilities of the E5 mutant proteins to associate the PDGF-R and to transform cells. However, all transforming E5 mutant proteins induced PDGF-R tyrosine phosphorylation. In NIH 3T3 and C127 mouse fibroblasts, both transforming and nontransforming E5 mutant proteins were defective for PDGF-R binding. In addition, while most of the transforming E5 proteins induced PDGF-R phosphorylation, one hypertransforming mutant (serine 17) neither bound nor induced receptor autophosphorylation. These findings support the hypothesis that the transformation of fibroblasts by E5 transmembrane mutants can involve alternative cellular targets or potentially independent activities of the E5 protein. In addition, these results underscore the critical role of the transmembrane domain in mediating E5 biological activities.

This article has been cited by other articles:

• DeMasi, J., Huh, K.-W., Nakatani, Y., Munger, K., Howley, P. M. (2005). Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding. Proc. Natl. Acad. Sci. USA 102: 11486-11491 [Abstract] [Full Text]  
• Lai, C.-C., Edwards, A. P. B., DiMaio, D. (2005). Productive Interaction between Transmembrane Mutants of the Bovine Papillomavirus E5 Protein and the Platelet-Derived Growth Factor {beta} Receptor. J. Virol. 79: 1924-1929 [Abstract] [Full Text]  
• Bohl, J., Hull, B., Vande Pol, S. B. (2001). Cooperative Transformation and Coexpression of Bovine Papillomavirus Type 1 E5 and E7 Proteins. J. Virol. 75: 513-521 [Abstract] [Full Text]  
• Ashrafi, G. H., Pitts, J. D., Faccini, A., McLean, P., O’Brien, V., Finbow, M. E., Campo, S. (2000). Binding of bovine papillomavirus type 4 E8 to ductin (16K proteolipid), down-regulation of gap junction intercellular communication and full cell transformation are independent events. J. Gen. Virol. 81: 689-694 [Abstract] [Full Text]  
• Suprynowicz, F. A., Sparkowski, J., Baege, A., Schlegel, R. (2000). E5 Oncoprotein Mutants Activate Phosphoinositide 3-Kinase Independently of Platelet-derived Growth Factor Receptor Activation. J. Biol. Chem. 275: 5111-5119 [Abstract] [Full Text]  
• Schapiro, F., Sparkowski, J., Adduci, A., Suprynowicz, F., Schlegel, R., Grinstein, S. (2000). Golgi Alkalinization by the Papillomavirus E5 Oncoprotein. J. Cell Biol. 148: 305-316 [Abstract] [Full Text]  
• Heldin, C.-H., Westermark, B. (1999). Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor. Physiol. Rev. 79: 1283-1316 [Abstract] [Full Text]  
• Adduci, A. J., Schlegel, R. (1999). The Transmembrane Domain of the E5 Oncoprotein Contains Functionally Discrete Helical Faces. J. Biol. Chem. 274: 10249-10258 [Abstract] [Full Text]  
• Klein, O., Kegler-Ebo, D., Su, J., Smith, S., DiMaio, D. (1999). The Bovine Papillomavirus E5 Protein Requires a Juxtamembrane Negative Charge for Activation of the Platelet-Derived Growth Factor beta  Receptor and Transformation of C127 Cells. J. Virol. 73: 3264-3272 [Abstract] [Full Text]  
• Lai, C.-C., Henningson, C., DiMaio, D. (1998). Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor beta  receptor. Proc. Natl. Acad. Sci. USA 95: 15241-15246 [Abstract] [Full Text]  
• Klein, O., Polack, G. W., Surti, T., Kegler-Ebo, D., Smith, S. O., DiMaio, D. (1998). Role of Glutamine 17 of the Bovine Papillomavirus E5 Protein in Platelet-Derived Growth Factor beta  Receptor Activation and Cell Transformation. J. Virol. 72: 8921-8932 [Abstract] [Full Text]